QSI
Price
$1.74
Change
+$0.13 (+8.07%)
Updated
Dec 1, 6:59 PM EST
93 days until earnings call
SAGE
Price
$20.39
Change
+$0.81 (+4.14%)
Updated
Dec 1, 6:59 PM EST
82 days until earnings call
Ad is loading...

QSI vs SAGE ᐉ Comparison: Which is Better to Invest?

Header iconQSI vs SAGE Comparison
Open Charts QSI vs SAGEBanner chart's image
Quantum-Si
Price$1.74
Change+$0.13 (+8.07%)
Volume$478.85K
CapitalizationN/A
Sage Therapeutics
Price$20.39
Change+$0.81 (+4.14%)
Volume$554.71K
CapitalizationN/A
View a ticker or compare two or three
QSI vs SAGE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
QSI vs. SAGE commentary
Dec 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QSI is a StrongBuy and SAGE is a StrongBuy.

COMPARISON
Comparison
Dec 03, 2023
Stock price -- (QSI: $1.73 vs. SAGE: $20.39)
Brand notoriety: QSI and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QSI: 122% vs. SAGE: 102%
Market capitalization -- QSI: $211.17M vs. SAGE: $1.15B
QSI [@Biotechnology] is valued at $211.17M. SAGE’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QSI’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • QSI’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QSI’s TA Score shows that 5 TA indicator(s) are bullish while SAGE’s TA Score has 5 bullish TA indicator(s).

  • QSI’s TA Score: 5 bullish, 4 bearish.
  • SAGE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QSI is a better buy in the short-term than SAGE.

Price Growth

QSI (@Biotechnology) experienced а +13.07% price change this week, while SAGE (@Biotechnology) price change was +4.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

QSI is expected to report earnings on Mar 04, 2024.

SAGE is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for QSI with price predictions.
OPEN
A.I.dvisor published
a Summary for SAGE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SAGE($1.15B) has a higher market cap than QSI($211M). QSI has higher P/E ratio than SAGE: QSI (4.60) vs SAGE (2.85). QSI YTD gains are higher at: -5.464 vs. SAGE (-46.539). QSI has higher annual earnings (EBITDA): -126.87M vs. SAGE (-656.8M). SAGE has more cash in the bank: 876M vs. QSI (275M). SAGE has less debt than QSI: SAGE (6.97M) vs QSI (15.5M). SAGE has higher revenues than QSI: SAGE (11.3M) vs QSI (682K).
QSISAGEQSI / SAGE
Capitalization211M1.15B18%
EBITDA-126.87M-656.8M19%
Gain YTD-5.464-46.53912%
P/E Ratio4.602.85161%
Revenue682K11.3M6%
Total Cash275M876M31%
Total Debt15.5M6.97M222%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QSISAGE
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 17 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STSCX54.641.28
+2.40%
Sterling Capital SmCp Val Instl
VMGMX89.311.41
+1.60%
Vanguard Mid-Cap Growth Index Admiral
BAGAX24.250.26
+1.08%
Brown Advisory Growth Equity Adv
TEURX23.000.20
+0.88%
Franklin Mutual International Value C
ARIHX10.29N/A
N/A
Aristotle Small/Mid Cap Equity I

QSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, QSI has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QSI
1D Price
Change %
QSI100%
+7.45%
AXON - QSI
49%
Loosely correlated
+0.70%
RXRX - QSI
44%
Loosely correlated
+7.88%
ABCL - QSI
44%
Loosely correlated
+2.55%
CRSP - QSI
43%
Loosely correlated
+2.89%
VCYT - QSI
42%
Loosely correlated
+3.67%
More